RAD Abstract Submission Key Dates Abstract Submission Opens: Monday, December 1, 2025 Abstract Submission Deadline: Friday, May 1, 2026 Abstract Acceptance Notifications: Rolling; notifications sent within ~3 weeks of submission Pre-Conference Abstract Availability: Wednesday, June 17, 2026 – 7:00 AM (CT) Post-Conference Availability: Permanent Submission Format Requirements General Abstracts must be submitted in English Abstracts must be submitted as a PDF 600-word limit Word count excludes: Title Authors Affiliations Keywords References Disclosures One (1) chart or graph may be included Will appear on the RAD website Will not appear in the British Journal of Dermatology (BJD) Content RequirementsAbstracts may include: Scientific questions or challenges Clinical observations Primary research or scientific data Encore presentations (previously presented data) Title & Author Formatting Include: Full title Author full names (first, last, middle initial if applicable) Author institution (name, city, state/province, country) Title should be bold, sentence case Affiliations should use superscript numbering Double-space the abstract Disclosure Requirements Full disclosures must appear: In the abstract On the poster Presenting/first author must disclose for themselves and all co-authors for the prior 12 months Disclosures should include: Commercial entity names Nature of the relationship (e.g., Consultant, Employee, Lecture fees, Grant support) If none exist, indicate “None” Poster Presentation Requirements High-resolution PDF must be uploaded by Friday, May 22, 2026, at 11:59 PM (ET) via the link provided in the acceptance email. Poster may be formatted as: A single 16×9 PowerPoint slide Presenter must: Agree to present at the scheduled session Be present on site during the poster session Posters will be accessible: In-person in the poster hall On the RAD website AI-Generated Posters Prohibited: Posters or presentations generated by ChatGPT or other AI tools will not be accepted. Presentation Rules Non-accredited posters (website only): A non-author may present. An industry employee may present. Accredited posters or oral presentations: A non-author may not present. An industry employee may not present — must be presented by a non-industry author. Policies & Restrictions No QR codes allowed on posters No brand names, trademarks, or logos Only generic names permitted Copyright remains with the authors Previous or Ongoing Data Encore and adapted presentations are permitted Must provide: Conference or publication name Presentation/publication date Venue Trial-in-progress abstracts are allowed Abstract describing study design only may be submitted Results preferred if available Embargo Policy Encore presentations: No embargo Primary data: Data must not be publicly disclosed before conference presentation Press releases allowed beforehand only if data are not included Publication Details All accepted abstracts will be published: In the British Journal of Dermatology On the RAD website Costs & Fees No abstract submission fee Modifications After Submission Abstracts may be edited after submission Use the unique link provided in the acceptance notification email Assistance & SupportFor questions: Email multi-info@gotoper.com Include: Abstract number Submitter name Responses will only be provided to those with an assigned abstract number. Submitter/Author Details Question Title * 1. First Name Question Title * 2. Last Name Question Title * 3. Company Question Title * 4. Designation/Credentials (Student, Resident, Pre-Residency Fellow, or Post-Residency Fellow) Question Title * 5. Poster Title Question Title * 6. Country Question Title * 7. Email Address Question Title * 8. Co-Author Details Question Title * 9. Abstract Title Question Title * 10. Abstract Type Question Title * 11. Background Question Title * 12. Materials and Methods Question Title * 13. Results Question Title * 14. Conclusions Question Title * 15. Is this an encore presentation? Yes No Question Title * 16. If yes where was it previously presented? Question Title * 17. Financial Relationships to Disclose Neither I, the undersigned, nor my spouse or domestic partner, have had within the past 12-months, financial relationships with commercial interests that are relevant to the content for which I am responsible I, the undersigned, and/or my spouse or domestic partner, have had within the past 12-months, financial relationships with commercial interests that are relevant to the content for which I am responsible. Below is a listing of the commercial interest(s) Next